127 related articles for article (PubMed ID: 37084522)
21. Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease.
Furukawa K; Shima A; Kambe D; Nishida A; Wada I; Sakamaki H; Yoshimura K; Terada Y; Sakato Y; Mitsuhashi M; Sawamura M; Nakanishi E; Taruno Y; Yamakado H; Fushimi Y; Okada T; Nakamoto Y; Takahashi R; Sawamoto N
Ann Neurol; 2022 Jul; 92(1):110-121. PubMed ID: 35428994
[TBL] [Abstract][Full Text] [Related]
22. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
23. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
[TBL] [Abstract][Full Text] [Related]
24. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
[TBL] [Abstract][Full Text] [Related]
25. Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease.
Fedorova TD; Knudsen K; Horsager J; Hansen AK; Okkels N; Gottrup H; Vang K; Borghammer P
J Parkinsons Dis; 2023; 13(4):515-523. PubMed ID: 37212074
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and
Kuya K; Ogawa T; Shinohara Y; Ishibashi M; Fujii S; Mukuda N; Tanabe Y
Acta Radiol; 2018 May; 59(5):593-598. PubMed ID: 28743197
[TBL] [Abstract][Full Text] [Related]
27. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
28. In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls. A preliminary report.
Tabet N; Walker Z; Mantle D; Costa D; Orrell M
Dement Geriatr Cogn Disord; 2003; 16(1):46-51. PubMed ID: 12714800
[TBL] [Abstract][Full Text] [Related]
29. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
30. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias.
Colloby SJ; McParland S; O'Brien JT; Attems J
Brain; 2012 Sep; 135(Pt 9):2798-808. PubMed ID: 22961551
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic connectivity reconfiguration in the dementia with Lewy bodies continuum.
Caminiti SP; Pilotto A; Premi E; Galli A; Ferrari E; Gipponi S; Cottini E; Paghera B; Perani D; Padovani A
Parkinsonism Relat Disord; 2023 Mar; 108():105288. PubMed ID: 36724569
[TBL] [Abstract][Full Text] [Related]
32. The utility of the combined use of
Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
[TBL] [Abstract][Full Text] [Related]
33. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
34. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies.
Walker RW; Walker Z
Mov Disord; 2009; 24 Suppl 2():S754-9. PubMed ID: 19877236
[TBL] [Abstract][Full Text] [Related]
35. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
Berman SB; Miller-Patterson C
Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
[TBL] [Abstract][Full Text] [Related]
36. Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
Rahman MGM; Islam MM; Tsujikawa T; Kiyono Y; Okazawa H
Ann Nucl Med; 2019 Jan; 33(1):14-21. PubMed ID: 30276622
[TBL] [Abstract][Full Text] [Related]
37. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
Happe S; Baier PC; Helmschmied K; Meller J; Tatsch K; Paulus W
J Neurol; 2007 Aug; 254(8):1037-43. PubMed ID: 17351722
[TBL] [Abstract][Full Text] [Related]
38. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
[TBL] [Abstract][Full Text] [Related]
39. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
40. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
